Clinical Trials Directory

Trials / Completed

CompletedNCT06376591

Assessing the Efficacy of Different Carrier Systems in Oral Vitamin B12 Supplementation

Assessing the Efficacy of Different Carrier Systems in Oral Vitamin B12 Supplementation in Improving Circulatory B12 Levels in Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Liaquat University of Medical & Health Sciences · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Vitamin B12, a vital nutrient, plays a crucial role in red blood cell formation, neurological function, and DNA synthesis. Deficiency in B12 can lead to anemia, neurological symptoms such as tingling or numbness, and cognitive impairment. Oral B12 supplementation serves as an effective strategy to address B12 deficiency, especially for individuals with limited dietary intake or absorption issues. Regular B12 supplementation can help restore body B12 levels, alleviate deficiency-related symptoms, and support overall health and well-being.

Detailed description

The carrier system in oral vitamin B12 supplements plays a pivotal role in ensuring the stability and efficacy of the supplement. It helps protect the vitamin from degradation in the acidic environment of the stomach, enhancing its bioavailability. Additionally, the carrier system facilitates the transport of vitamin B12 across the gastrointestinal tract, promoting optimal absorption. By optimizing the delivery of B12 to the small intestine, the carrier system maximizes its potential for absorption into the bloodstream. Overall, the choice of carrier system significantly impacts the effectiveness of oral B12 supplementation in addressing deficiency and improving health outcomes. Limited research exists regarding the exploration of various carrier systems used in oral B12 supplementation. This gap hinders a comprehensive understanding of how different carriers affect B12 absorption and efficacy. Further studies are needed to elucidate the optimal carrier system for maximizing B12 bioavailability and improving clinical outcomes. Expanding research in this area can enhance our knowledge and guide the development of more effective oral B12 supplements. This study aims to compare the efficacy of sucrosomial and non-sucrosomial carrier systems in delivering vitamin B12 orally. By assessing absorption kinetics and clinical outcomes, we seek to determine the superiority of the sucrosomial carrier system in enhancing B12 bioavailability. Insights from this research could help in the development of more effective oral B12 supplements.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVit B12Sucrosomial® B12
DIETARY_SUPPLEMENTVit B12B-SUB® B12
DIETARY_SUPPLEMENTVit B12Mecogen SL® B12
DIETARY_SUPPLEMENTVit B12Evermin® B12
DIETARY_SUPPLEMENTVit B12Neuromax® B12

Timeline

Start date
2024-04-12
Primary completion
2024-07-07
Completion
2024-07-14
First posted
2024-04-19
Last updated
2024-07-18

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06376591. Inclusion in this directory is not an endorsement.